Eloxx Pharmaceuticals Inc.

ELOX | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.45

+$0.27 (+2.05%)

At close: Oct 30, 2026, 4:00 PM ET

$13.90

+$0.45 (+3.35%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $46.22M

Enterprise Value $-15.74M

Beta -9.95

Average Volume 43.34K

Shares Outstanding (Diluted) 6.79M

Shares Change YoY 3275.63%

Institutional Ownership 36.82%

Exchange NASDAQ

ISIN US29014R3012

Price Performance

Price Change 1M -12.2%

Price Change 3M -22.8%

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) -22.9%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR 66.7%

Valuation

PE Ratio -8.85

Forward PE 0.54

PEG Ratio -0.10

Forward PEG 0.09

PS Ratio N/A

Forward PS 0.30

PB Ratio 1.00

P/FCF Ratio -4.51

P/Adj. FCF Ratio -4.45

P/OCF Ratio -8.91

EV/Sales N/A

EV/EBIT 1.93

EV/EBITDA 1.93

EV/FCF 1.54

Earnings Yield -11.3%

FCF Yield -22.2%

Adj. FCF Yield -22.5%

Financial Health

Net Cash $61.96M

Total Debt $0

Cash & Short-Term Investments $61.96M

Total Assets $63.39M

Current Ratio 3.74

Quick Ratio 3.74

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -222.84

Altman Z-Score -4.73

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -1.4%

Returns

Return on Assets -13.0%

Return on Equity -42.5%

Return on Invested Capital -17.8%

Return on Capital Employed -17.8%

Return on Tangible Assets -13.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 0.0%

Revenue CAGR 5Y 50.0%

Revenue CAGR 10Y 41.3%

EPS CAGR 3Y 95.8%

EPS CAGR 5Y 51.2%

EPS CAGR 10Y 38.8%

FCF CAGR 3Y 63.5%

FCF CAGR 5Y 27.8%

FCF CAGR 10Y 6.4%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y -24.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.58

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $36.67

Price Target Upside 172.6%

Cash Flow

Operating Cash Flow $-10.24M

Free Cash Flow $-10.24M

Adj. Free Cash Flow $-10.38M

FCF Per Share -$1.51

OCF Per Share -$1.51

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-8.25M

EBITDA $-8.18M

Net Income $-8.26M

EPS (Diluted) -$1.52

Revenue / Employee N/A

Profit / Employee $-825.6K

Employees 10